Vivencio Barrios

7.8k total citations
353 papers, 4.1k citations indexed

About

Vivencio Barrios is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Vivencio Barrios has authored 353 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 267 papers in Cardiology and Cardiovascular Medicine, 108 papers in Surgery and 71 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Vivencio Barrios's work include Blood Pressure and Hypertension Studies (131 papers), Atrial Fibrillation Management and Outcomes (59 papers) and Lipoproteins and Cardiovascular Health (54 papers). Vivencio Barrios is often cited by papers focused on Blood Pressure and Hypertension Studies (131 papers), Atrial Fibrillation Management and Outcomes (59 papers) and Lipoproteins and Cardiovascular Health (54 papers). Vivencio Barrios collaborates with scholars based in Spain, Germany and United States. Vivencio Barrios's co-authors include Carlos Escobar, Alberto Calderón, J.L. Llisterri, Carlos Escobar, Mariano de la Figuera, Carlos Escobar, Luís M. Ruilope, José Ramón González‐Juanatey, Diego González-Segura Alsina and J.A. Divisón and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

Vivencio Barrios

314 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vivencio Barrios Spain 34 2.7k 905 902 421 400 353 4.1k
Maria Carla Roncaglioni Italy 25 1.5k 0.6× 813 0.9× 798 0.9× 196 0.5× 306 0.8× 101 3.8k
Vicente Bertoméu Spain 32 2.6k 1.0× 498 0.6× 891 1.0× 237 0.6× 260 0.7× 243 3.5k
Jean‐Pierre Boissel France 22 1.7k 0.6× 458 0.5× 513 0.6× 168 0.4× 394 1.0× 53 2.9k
Mátyás Keltai Hungary 30 5.3k 2.0× 1.5k 1.6× 1.8k 1.9× 289 0.7× 900 2.3× 71 7.0k
Steen Z. Abildstrøm Denmark 36 4.1k 1.5× 675 0.7× 1.3k 1.4× 421 1.0× 455 1.1× 110 6.7k
Shelly Sapp United States 32 3.4k 1.3× 269 0.3× 2.1k 2.3× 252 0.6× 518 1.3× 56 7.1k
Dave L. Dixon United States 30 1.3k 0.5× 782 0.9× 977 1.1× 359 0.9× 105 0.3× 151 3.7k
Daniel E. Hilleman United States 31 1.1k 0.4× 434 0.5× 638 0.7× 186 0.4× 182 0.5× 147 3.3k
John Goudevenos Greece 38 3.1k 1.1× 723 0.8× 1.6k 1.8× 129 0.3× 416 1.0× 194 6.3k
Joan Sala Spain 36 2.4k 0.9× 924 1.0× 1.0k 1.1× 374 0.9× 116 0.3× 122 4.3k

Countries citing papers authored by Vivencio Barrios

Since Specialization
Citations

This map shows the geographic impact of Vivencio Barrios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivencio Barrios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivencio Barrios more than expected).

Fields of papers citing papers by Vivencio Barrios

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivencio Barrios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivencio Barrios. The network helps show where Vivencio Barrios may publish in the future.

Co-authorship network of co-authors of Vivencio Barrios

This figure shows the co-authorship network connecting the top 25 collaborators of Vivencio Barrios. A scholar is included among the top collaborators of Vivencio Barrios based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivencio Barrios. Vivencio Barrios is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Escobar, Carlos, Xavier Aldeguer, David Vivas, et al.. (2025). The gut microbiota and its role in the development of cardiovascular disease. Expert Review of Cardiovascular Therapy. 23(1-2). 23–34. 6 indexed citations
2.
Gimeno-Orna, José Antonio, Luis Rodrı́guez Padial, Javier Muñiz, et al.. (2025). HFpEF as the predominant and underrecognized heart failure phenotype in type 2 diabetes: evidence from the DIABET-IC study. Cardiovascular Diabetology. 24(1). 419–419.
3.
Padial, Luis Rodrı́guez, et al.. (2024). Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial. Endocrinología Diabetes y Nutrición (English ed ). 71(7). 278–289.
4.
Fácila, Lorenzo, et al.. (2023). Nuevas tecnologías para el diagnóstico, tratamiento y seguimiento de las enfermedades cardiovasculares. Revista Española de Cardiología. 77(1). 88–96. 4 indexed citations
5.
Escobar, Carlos, Vivencio Barrios, Ángel Cequier, et al.. (2023). Impact of the Spanish consensus for improving lipid control on patients admitted for an acute coronary syndrome. Journal of clinical lipidology. 17(6). 756–764. 5 indexed citations
6.
Barrios, Vivencio, Eduardo Barge‐Caballero, Carlos Escobar, et al.. (2023). Situación actual del abordaje integral de la insuficiencia cardiaca en España. Proyecto OPTIMISE-IC. REC CardioClinics. 58(4). 289–302.
7.
Barrios, Vivencio, et al.. (2022). Conocimiento del cardiólogo clínico sobre diabetes mellitus tipo 2 de alto riesgo. ¿Qué sabemos y cómo podemos mejorar?. REC CardioClinics. 57(4). 263–270. 1 indexed citations
8.
Barrios, Vivencio, Carlos Escobar, Vicente Arrarte, et al.. (2021). Analysis of the prescription process of PCSK9 inhibitors in the cardiology departments of Spanish hospitals and optimization proposal. The IKIGAI study. Clínica e Investigación en Arteriosclerosis (English Edition). 33(6). 296–305. 2 indexed citations
9.
Barrios, Vivencio, Carlos Escobar, Manuel Anguita, et al.. (2021). Recommendations to improve lipid control in primary prevention patients. A consensus document of the Spanish Society of Cardiology. REC CardioClinics. 56(3). 208–217. 3 indexed citations
10.
Barrios, Vivencio, Carlos Escobar, Manuel Anguita, et al.. (2021). Recomendaciones para mejorar el control lipídico en pacientes en prevención primaria. Documento de consenso de la Sociedad Española de Cardiología. REC CardioClinics. 56(2). 118–128. 3 indexed citations
11.
Pallarés‐Carratalá, Vicente, et al.. (2021). Posicionamiento SEMERGEN en el abordaje de la insuficiencia cardíaca crónica en atención primaria. Medicina de Familia SEMERGEN. 48(2). 106–123. 4 indexed citations
12.
Barrios, Vivencio, et al.. (2020). First national registry on the effectiveness and safety of evolocumab in clinical practice in patients attended in cardiology in Spain. The RETOSS-CARDIO study. Clínica e Investigación en Arteriosclerosis (English Edition). 32(6). 231–241. 3 indexed citations
13.
Núñez-Cortés, Jesús Millán, et al.. (2016). Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study. American Journal of Cardiovascular Drugs. 17(2). 135–142. 16 indexed citations
14.
Barrios, Vivencio, José Polo García, Carlos Escobar, et al.. (2016). Evaluation of SAMe-TT 2 R 2 score and other clinical factors influencing the quality of anticoagulation therapy in non-valvular atrial fibrillation: a nationwide study in Spain. Current Medical Research and Opinion. 32(7). 1201–1207. 21 indexed citations
15.
Lorgelly, Paula, Andrew Briggs, Hans Wedel, et al.. (2009). An Economic Evaluation of Rosuvastatin Treatment in Systolic Heart Failure: Evidence from the CORONA Trial. European Journal of Heart Failure. 12(1). 66–74. 14 indexed citations
16.
Barrios, Vivencio, et al.. (2008). Correction. Heart. 94(7). 935.3–935. 2 indexed citations
17.
Barrios, Vivencio, Carlos Escobar, Mariano de la Figuera, et al.. (2008). Tolerability of High Doses of Lercanidipine versus High Doses of Other Dihydropyridines in Daily Clinical Practice: The TOLERANCE Study. Cardiovascular Drug Reviews. 26(1). 2–9. 10 indexed citations
18.
Barrios, Vivencio. (2004). Insuficiencia cardíaca con función ventricular deprimida: Estudio CHARM. 4(2). 12–20. 2 indexed citations
19.
Pitt, Bertram, Vivencio Barrios, Barbara Roniker, et al.. (2002). Efficacy and Safety of Eplerenone Compared to Enalapril in Left Ventricular Hypertrophy. Japanese Circulation Journal-english Edition. 66. 139. 1 indexed citations
20.
Ruilope, Luís M., Vivencio Barrios, J. Segura, & Carlos Campo. (1999). The kidney in heart failure: role of angiotensin II. Current Opinion in Nephrology & Hypertension. 8(2). 153–156. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Carla Roncaglioni Breakdown of academic impact, for papers by Vicente Bertoméu Breakdown of academic impact, for papers by Jean‐Pierre Boissel Breakdown of academic impact, for papers by Mátyás Keltai Breakdown of academic impact, for papers by Steen Z. Abildstrøm Breakdown of academic impact, for papers by Shelly Sapp Breakdown of academic impact, for papers by Dave L. Dixon Breakdown of academic impact, for papers by Daniel E. Hilleman Breakdown of academic impact, for papers by John Goudevenos Breakdown of academic impact, for papers by Joan Sala
Rankless by CCL
2026